Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An announcement from HemoGenyx Pharmaceuticals Plc ( (GB:HEMO) ) is now available.
Hemogenyx Pharmaceuticals plc has announced its total issued share capital as of January 31, 2025, which consists of 3,604,539 ordinary shares. This figure is important for shareholders as it is used to calculate their investment interests under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
More about HemoGenyx Pharmaceuticals Plc
Hemogenyx Pharmaceuticals plc is a biopharmaceutical company focused on developing new therapies and treatments for blood diseases.
YTD Price Performance: -10.0%
Average Trading Volume: 26,901
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £13.14M
See more data about HEMO stock on TipRanks’ Stock Analysis page.